Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0X89S | ISIN: US4967191051 | Ticker-Symbol:
NASDAQ
17.01.25
21:59 Uhr
15,400 US-Dollar
+0,120
+0,79 %
1-Jahres-Chart
KINGSTONE COMPANIES INC Chart 1 Jahr
5-Tage-Chart
KINGSTONE COMPANIES INC 5-Tage-Chart
ACCESS Newswire
481 Leser
Artikel bewerten:
(2)

Kingstone Companies, Inc: Kingstone Chairman Barry Goldstein Announces His Retirement

Finanznachrichten News

KINGSTON, NY / ACCESSWIRE / August 29, 2024 / Kingstone Companies, Inc. (Nasdaq:KINS) (the "Company" or "Kingstone"), a Northeast regional property and casualty insurance holding company, announced today that Barry Goldstein, its long-time Chairman of the Board of Directors, will retire effective Tuesday, September 10, 2024. Thomas Newgarden, who joined the Company's board earlier this year, will become Kingstone's Non-Executive Chairman concurrent with Mr. Goldstein's departure.

Mr. Goldstein has served as the Company's Chairman of the Board since March 2001 and served as its Chief Executive Officer from March 2001 to December 2018 and from July 2019 to September 2023. He has been the Chairman of Kingstone Insurance Company, the Company's operating insurance company subsidiary, for the past eighteen years.

A few years after joining Kingstone, Mr. Goldstein led the Company (then an insurance agency) to a Nasdaq listing in October 2004. In 2005, after the Company acquired the $3.75 million of surplus notes issued by Commercial Mutual Insurance Company ("CMIC"), an insurance company, he became CMIC's Chairman and engineered its demutualization. Determined to focus solely on underwriting, the Company sold off its agency and premium finance assets and acquired 100% equity ownership of CMIC in July 2009 (renaming it Kingstone Insurance Company ("KICO"), with the parent company being named Kingstone Companies, Inc.). Over the subsequent fifteen years, KICO grew to write over $200 million in annual premiums and become the 15th largest writer of homeowners insurance in New York State. KICO recently reported the most profitable quarter in its 138-year history.

"Meryl and I have planned for this succession, beginning with her assuming the Chief Executive Officer position last October. Kingstone's plan to return to profitability is in place and working. We moved to strengthen the Board, further build the leadership team and manage our debt maturity. Everything we hoped to accomplish is in place and now is an incredibly good time for me to retire," said Mr. Goldstein. "It has been an honor to have led Kingstone for more than two decades. I am totally confident about the future of Kingstone under Meryl's leadership, and that the Board, now led by Tom Newgarden, will serve the shareholders' long-term best interests and guide the Company to continued success."

"On behalf of the entire Board of Directors, we wish to extend our sincere gratitude to Barry for over twenty years of devoted service to the Company," said Thomas Newgarden, Non-Executive Chairman of the Board.

"I am forever grateful for the mentorship and guidance that Barry has shared with me over the past five years as well as the invaluable insight and expertise he has provided to the Board and our organization over more than two decades," said Meryl Golden, Chief Executive Officer.

About Kingstone Companies, Inc.

Kingstone is a northeast regional property and casualty insurance holding company whose principal operating subsidiary is Kingstone Insurance Company ("KICO"). KICO is a New York domiciled carrier writing business through retail and wholesale agents and brokers. KICO is actively writing personal lines and commercial auto insurance in New York, and in 2023 was the 15th largest writer of homeowners insurance in New York. KICO is also licensed in New Jersey, Rhode Island, Massachusetts, Connecticut, Pennsylvania, New Hampshire, and Maine.

Forward-Looking Statements

Statements in this press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, may be forward-looking statements. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. These statements involve risks and uncertainties that could cause actual results to differ materially from those included in forward-looking statements due to a variety of factors. For more details on factors that could affect expectations, see Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission.

Kingstone undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Relations Contact:

Karin Daly
Vice President
The Equity Group Inc.
kdaly@equityny.com

SOURCE: Kingstone Companies, Inc



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.